BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24899056)

  • 1. Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy.
    Yao Y; Fomison-Nurse IC; Harrison JC; Walker RJ; Davis G; Sammut IA
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F251-62. PubMed ID: 24899056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy.
    Moya-Olano L; Milne HM; Robinson JM; Hill JV; Frampton CM; Abbott HF; Turner R; Kettle AJ; Endre ZH
    Pathol Int; 2011 Nov; 61(11):652-61. PubMed ID: 22029676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR).
    Kelly DJ; Wilkinson-Berka JL; Allen TJ; Cooper ME; Skinner SL
    Kidney Int; 1998 Aug; 54(2):343-52. PubMed ID: 9690200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
    Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL
    Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
    Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
    Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
    D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
    Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal functional responses in diabetic nephropathy following chronic bilateral renal denervation.
    Yao Y; Davis G; Harrison JC; Walker RJ; Sammut IA
    Auton Neurosci; 2017 May; 204():98-104. PubMed ID: 27727024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic bilateral renal denervation reduces cardiac hypertrophic remodelling but not β-adrenergic responsiveness in hypertensive type 1 diabetic rats.
    Thaung HP; Yao Y; Bussey CT; Hughes G; Jones PP; Bahn A; Sammut IA; Lamberts RR
    Exp Physiol; 2015 Jun; 100(6):628-39. PubMed ID: 25881071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
    Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
    Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats.
    Nicholas SB; Mauer M; Basgen JM; Aguiniga E; Chon Y
    Am J Nephrol; 2004; 24(5):549-56. PubMed ID: 15539791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
    Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
    Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of renal nerves in the development of diabetic nephropathy.
    Matsuoka H
    Diabetes Res; 1993; 23(1):19-29. PubMed ID: 7924145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes.
    Hartner A; Cordasic N; Klanke B; Wittmann M; Veelken R; Hilgers KF
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F820-7. PubMed ID: 17018847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats.
    Luippold G; Beilharz M; Mühlbauer B
    Nephrol Dial Transplant; 2004 Feb; 19(2):342-7. PubMed ID: 14736957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.
    Vandekerckhove L; Vermeulen Z; Liu ZZ; Boimvaser S; Patzak A; Segers VF; De Keulenaer GW
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E495-504. PubMed ID: 26786778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.